Targeted fetal cell ‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
ConclusionsTargeted NIPT results suggest that MiSeq platform could be used for NIPT which would be an essential option particularly for laboratories with low sample flow. And, the NextSeq platform has easier wet lab process and also increased success rate in automatic reporting which is suitable for centers with high number of NIPT cases.
Source: Molecular Genetics & Genomic Medicine - Category: Genetics & Stem Cells Authors: Altug Koc,
Ozge Ozer Kaya,
Berk Ozyilmaz,
Yasar B. Kutbay,
Ozgur Kirbiyik,
Taha R. Ozdemir,
Kadri M. Erdogan,
Merve Saka Guvenc,
Deniz C. Oztekin,
Mehmet Ozeren,
Halil G. Pala,
Atalay Ekin,
Cenk Gezer,
Alkim G. Sahingoz Yildirim,
Bahar Konur Tags: ORIGINAL ARTICLE Source Type: research
More News: Down's Syndrome | Edwards Syndrome | Genetics | Laboratory Medicine | Middle East Health | Pregnancy | Study | Turkey Health | Women